Cambridge Investment Research Advisors’s AtriCure ATRC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$477K	Buy	+17,045	New	+$480K	﹤0.01%	2785

Other funds holding ATRC

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Tactive Advisors Jacksonville, Florida $406M AUM 35.68% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBT

First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return

Cambridge Investment Research Advisors's ATRC Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in AtriCure (ATRC) in Q2 2026: 17,045 shares worth $477K. The stake represents ﹤0.01% of the portfolio and ranks #2785 among its holdings.

30 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Cambridge Investment Research Advisors held 17,045 shares of AtriCure worth $477K as of Q2 2026.
AtriCure was a new Cambridge Investment Research Advisors position in Q2 2026.
AtriCure made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2785 holding.
30 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.